Stay updated on Brexanolone Safety in Adolescent PPD Clinical Trial
Sign up to get notified when there's something new on the Brexanolone Safety in Adolescent PPD Clinical Trial page.

Latest updates to the Brexanolone Safety in Adolescent PPD Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page's revision tag was updated from v3.2.0 to v3.3.2, with no changes to study details or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the general government funding/operating status notice from the page. The deleted text previously directed users to cc.nih.gov for Clinical Center status and opm.gov for updates on government operating status.SummaryDifference0.4%

- Check43 days agoChange DetectedMinor UI/layout adjustments and updated timestamps were observed, with core study data remaining unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedUpdate adds a government-funding status notice and NIH Clinical Center operating details with a v3.2.0 revision, while removing the old v3.1.0 tag.SummaryDifference4%

- Check79 days agoChange DetectedUpgrade noted: version updated from v3.0.2 to v3.1.0. No other content changes detected.SummaryDifference0.1%

- Check86 days agoChange DetectedReplace Sage Therapeutics with Supernus Pharmaceuticals, Inc. and add new update timestamps including an Estimated Last Update Posted; marks a brand/company switch and new update timing.SummaryDifference2%

Stay in the know with updates to Brexanolone Safety in Adolescent PPD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Brexanolone Safety in Adolescent PPD Clinical Trial page.